m
Our Mission Statement
This is Photoshop's version of Loremer Ipsn gravida nibh vel velit auctoregorie sam alquet.Aenean sollicitudin, lorem quis bibendum auci elit consequat ipsutis sem nibh id elit.
Follow Us
Top
Transcell Oncologics presents it’s story at AAPM Annual Meeting 2019 – Transcell
7290
post-template-default,single,single-post,postid-7290,single-format-standard,mkd-core-1.0,unselectable,highrise-ver-1.0,,mkd-smooth-page-transitions,mkd-ajax,mkd-grid-1300,mkd-blog-installed,mkd-header-vertical,mkd-sticky-header-on-scroll-up,mkd-default-mobile-header,mkd-sticky-up-mobile-header,mkd-dropdown-slide-from-bottom,mkd-dark-header,mkd-full-width-wide-menu,mkd-search-dropdown,mkd-side-menu-slide-from-right,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

Blog

Transcell Oncologics presents it’s story at AAPM Annual Meeting 2019

Published Date: November 11th 2019
Location: California,USA

The AAPM Annual Meeting 2019 brought together top experts and thought leaders in the fields of precision medicine, life science, biotech, MedTech and pharma to Silicon Valley. With the theme as “Accelerating Precision Medicine and Transforming Patient Health,” AAPM 2019 was designed to bring the global community of researchers, industry, practitioners together showcasing their innovative interventions.

CEO of Transcell group, Dr S Dravida has shared Oncologics vision and mission as “Precision All the Way” in the meeting while showcasing the company’s vertical-specific offerings. Her presentation at 2019 AAPM meeting highlights the company’s product portfolio’s (www.transtoxbio.com) US market entry addressing pre-clinical research requirements.

No Comments

Leave a Comment

error: Content is protected !!